Agents for Detecting and Imaging Cell Death

This invention relates to molecular imaging agents comprising an S78C mutant synaptotagmin I C2A domain. These agents may be useful in detecting or assessing cell death in vitro and in vivo, for example in tumours following cancer treatment.

Patents:
US 20,110,038,798

Inventor(s): BRINDLE KEVIN [GB]; NEVES ANDRE [GB]; DE BACKER MAAIKE [NL]; ALAM ISRAT [GB]

Type of Offer: Sale